Moderna Inc

NASDAQ:MRNA

136.26

-7.12 (-4.97%)

Products, Community

FDA Considering Whether To Authorize Lower Dose Of Moderna's Covid-19 Vaccine For Boosters Than Dose Given In First Two Shots - WSJ

Published: 09/02/2021 15:01 GMT

MRNA

Moderna Inc (MRNA) - FDA Considering Whether to Authorize a Lower Dose of Moderna's Covid-19 Vaccine for Boosters Than the Dose Given in the First Two Shots - Wsj.